Development of fluorogenic and chemiluminogenic main protease substrates for cellular and in vivo imaging of SARS-CoV-2
- Funded by National Institutes of Health (NIH)
- Total publications:0 publications
Grant number: 5R21EB032983-02
Grant search
Key facts
Disease
COVID-19Start & end year
2022.02025.0Known Financial Commitments (USD)
$186,572Funder
National Institutes of Health (NIH)Principal Investigator
BOVAY CHAIR AND PROFESSOR Wenshe LiuResearch Location
United States of AmericaLead Research Institution
TEXAS A&M UNIVERSITYResearch Priority Alignment
N/A
Research Category
Pathogen: natural history, transmission and diagnostics
Research Subcategory
Diagnostics
Special Interest Tags
N/A
Study Type
Non-Clinical
Clinical Trial Details
N/A
Broad Policy Alignment
Pending
Age Group
Not Applicable
Vulnerable Population
Not applicable
Occupations of Interest
Not applicable
Abstract
PROJECT SUMMARY COVID-19 is the currently prevailing pandemic that has paralyzed much of the world. The viral pathogen of COVID-19 is SARS-CoV-2, a coronavirus with a positive sense RNA genome. Its production in the human cell host requires the activity of its main protease (MPro). As a unique enzyme that is essential to SARS-CoV-2, MPro is acutely toxic to the host cell indicating that it is tightly regulated during viral infection and replication. Its activity also represents active viral reproduction in organs and tissues in an infected host organism. Therefore, the detection of MPro activity in SARS-CoV-2-infected cells and animals will provide essential information about MPro activity regulation in the host cell and SARS-CoV-2 spreading and distribution in a host organism respectively for the elucidation of SARS-CoV-2 replication and pathogenesis. Noninvasive imaging reagents will be critical for the detection of MPro activity in order to avoid interference with both the virus and the host. With an ultimate goal of understanding the SARS-CoV-2 replication in infected cells and elucidating SARS-CoV-2 spreading patterns and organ/tissue distribution in infected animals, the current proposal aims to develop noninvasive fluorogenic and chemiluminogenic MPro substrates that have highly cellular stability and tissue penetrability for imaging MPro activity. Three specific aims will be pursued by 1) developing fluorogenic and chemiluminogenic MPro substrates; 2) characterizing fluorogenic and chemiluminogenic MPro substrates on their selectivity, cellular stability and tissue penetrability; and 3) conducting cellular and in vivo imaging of SARS-CoV-2 infection. The successful completion of the proposed study will 1) result in fluorogenic and chemiluminogenic MPro substrates with optimal cellular stability and tissue penetratability that can be broadly adopted by COVID-19 researchers for the investigation of SARS-CoV-2 replication and pathogenesis and 2) provide critical information for the elucidation of Mpro activity regulation in SARS-CoV-2-infected cells and SARS-CoV-2 spreading patterns and distribution in transgenic hACE2+ mice.